Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients.
Geng R, Tang H, You T, Xu X, Li S, Li Z, Liu Y, Qiu W, Zhou N, Li N, Ge Y, Guo F, Sun Y, Wang Y, Li T, Bai C.
Geng R, et al. Among authors: zhou n.
Front Immunol. 2023 Mar 10;14:1125876. doi: 10.3389/fimmu.2023.1125876. eCollection 2023.
Front Immunol. 2023.
PMID: 36969245
Free PMC article.